ADAM-8, a metalloproteinase, drives acute allergen-induced airway inflammation

Laboratory of Tumor and Development Biology, GIGA-Research (GIGA-I3 and GIGA-cancer), University of Liege and CHU of Liege, Sart-Tilman, Belgium.
European Journal of Immunology (Impact Factor: 4.52). 02/2011; 41(2):380-91. DOI: 10.1002/eji.200940286
Source: PubMed

ABSTRACT Asthma is a complex disease linked to various pathophysiological events including the activity of proteinases. The multifunctional A disintegrin and metalloproteinases (ADAMs) displaying the ability to cleave membrane-bound mediators or cytokines appear to be key mediators in various inflammatory processes. In the present study, we investigated ADAM-8 expression and production in a mouse model of allergen-induced airway inflammation. In allergen-exposed animals, increased expression of ADAM-8 was found in the lung parenchyma and in DC purified from the lungs. The potential role of ADAM-8 in the development of allergen-induced airway inflammation was further investigated by the use of an anti-ADAM-8 antibody and ADAM-8 knockout animals. We observed a decrease in allergen-induced acute inflammation both in BALF and the peribronchial area in anti-ADAM-8 antibody-treated mice and in ADAM-8-deficient mice (ADAM-8(-/-) ) after allergen exposure. ADAM-8 depletion led to a significant decrease of the CD11c(+) lung DC. We also report lower levels of CCL11 and CCL22 production in antibody-treated mice and ADAM-8- deficient mice that might be explained by decreased eosinophilic inflammation and lower numbers of DC, respectively. In conclusion, ADAM-8 appears to favour allergen-induced acute airway inflammation by promoting DC recruitment and CCL11 and CCL22 production.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Severe asthma and COPD are chronic inflammatory airway diseases in which the mechanisms are not fully understood. A Disintegrin And Metalloproteinase domain 8 (ADAM8) is an enzyme expressed on most leukocytes and may be important for facilitating leukocyte migration in respiratory disease. To investigate ADAM8 mRNA and protein expression in asthma and COPD and its relationship to asthma severity and inflammatory phenotypes. Induced sputum was collected from 113 subjects with asthma (Severe n=31, Uncontrolled n=39, Controlled n=35), 20 subjects with COPD and 21 healthy controls. Sputum ADAM8 mRNA expression was measured by qPCR, and soluble ADAM8 (sADAM8) protein was measured in the sputum supernatant by validated ELISA. ADAM8 mRNA correlated with ADAM8 protein levels (r=0.27, p<0.01). ADAM8 mRNA (p=0.004) and sADAM8 protein (p=0.014) levels were significantly higher in both asthma and COPD compared to healthy controls. ADAM8 mRNA (p=0.035) and sADAM8 protein (p=0.002) levels were significantly higher in severe asthma compared to controlled asthma. Total inflammatory cell count (p<0.01) and neutrophils (p<0.01) were also elevated in severe asthmatic sputum. Although ADAM8 mRNA was significantly higher in eosinophilic and neutrophilic asthma (p<0.001), sADAM8 did not differ between asthma inflammatory phenotypes. ADAM8 expression positively correlated with sputum total cell count and sputum neutrophils. ADAM8 expression is increased in both severe asthma and COPD and associated with sputum total cell count and neutrophils. ADAM8 may facilitate neutrophil migration to the airways in severe asthma and COPD. This article is protected by copyright. All rights reserved.
    Clinical & Experimental Allergy 10/2013; 44(3). DOI:10.1111/cea.12223 · 4.32 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Acute and chronic lung inflammation are driven and controlled by several endogenous mediators that undergo proteolytic conversion from surface expressed proteins to soluble variants by a disintegrin and metalloproteinase (ADAM) family members. TNF and epidermal growth factor receptor ligands are just some of the many substrates by which these proteases regulate inflammatory or regenerative processes in the lung. ADAM10 and ADAM17 are the most prominent members of this protease family. They are constitutively expressed in most lung cells and - as recent research has shown - are the pivotal shedding enzymes mediating acute lung inflammation in a cell-specific manner. ADAM17 promotes endothelial and epithelial permeability, transendothelial leukocyte migration, and inflammatory mediator production by smooth muscle and epithelial cells. ADAM10 is critical for leukocyte migration and alveolar leukocyte recruitment. ADAM10 also promotes allergic asthma by driving B-cell responses. Additionally, ADAM10 acts as a receptor for Staphylococcus aureus α-toxin and is crucial for bacterial virulence. ADAM8, ADAM9, ADAM15 and ADAM33 are upregulated during acute or chronic lung inflammation, and recent functional or genetic analyses have linked them to disease development. Pharmacological inhibitors that allow to locally or systemically target and differentiate ADAM-family members in the lung suppress acute and asthmatic inflammatory responses and S. aureus virulence. These promising results encourage further research to develop therapeutic strategies based on selected ADAMs. These studies need also to address the role of the ADAMs in repair and regeneration in the lung to identify further therapeutic opportunities and possible side effects. Copyright © 2014, American Journal of Physiology - Lung Cellular and Molecular Physiology.
    AJP Lung Cellular and Molecular Physiology 12/2014; 308(4):ajplung.00294.2014. DOI:10.1152/ajplung.00294.2014 · 4.04 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Airway inflammation has been suggested as pathological basis in asthma pathogenesis. Recruitment of leukocytes from the vasculature into airway sites is essential for induction of airway inflammation, a process thought to be mediated by A disintegrin and metalloprotease 8 (ADAM8). However, there is an apparent controversy about whether ADAM8 helps or hampers transmigration of leukocytes through endothelium in airway inflammation of asthma. This review outlines the current contradictory concepts concerning the role of ADAM8 in airway inflammation, particularly focusing on the recruitment of leukocytes during asthma, and attempts to bridge the existing experimental data based on the functional analysis of different domains of ADAM8 and their endogenous processing in vivo. A possible hypothesis for the specific mechanism of ADAM8 in regulation of trans-migration of leukocytes is raised to explain the disparity existing in current studies, together with some open questions that require future study.
    American Journal of Respiratory Cell and Molecular Biology 07/2013; DOI:10.1165/rcmb.2013-0168TR · 4.11 Impact Factor

Full-text (2 Sources)

Available from
Jun 5, 2014